tiprankstipranks
Trending News
More News >
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market

Concord Biotech Ltd. (CONCORDBIO) Income Statement

Compare
1 Followers

Concord Biotech Ltd. Income Statement

Last quarter (Q3 2025), Concord Biotech Ltd.'s total revenue was ₹2.44B, an increase of 1.42% from the same quarter last year. In Q3, Concord Biotech Ltd.'s net income was ₹759.21M. See Concord Biotech Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 12.00B₹ 9.98B₹ 8.53B₹ 7.08B₹ 6.04B
Gross Profit
₹ 5.89B₹ 7.53B₹ 6.73B₹ 5.31B₹ 4.84B
Operating Expenses
₹ 1.37B₹ 1.46B₹ 3.84B₹ 2.94B₹ 1.80B
Depreciation and Amortization
₹ 543.74M₹ 535.91M₹ 540.32M₹ 500.50M₹ 275.23M
EBITDA
₹ 5.51B₹ 4.66B₹ 3.83B₹ 2.97B₹ 3.42B
Operating Income
₹ 4.52B₹ 6.26B₹ 3.27B₹ 2.44B₹ 3.07B
Other Income/Expenses
₹ 439.17M₹ -2.14B₹ -1.96B₹ -1.75B₹ 94.68M
Pretax Income
₹ 4.96B₹ 4.13B₹ 3.22B₹ 2.38B₹ 3.13B
Net Income
₹ 3.72B₹ 3.08B₹ 2.40B₹ 1.75B₹ 2.35B
Per Share Metrics
Basic EPS
₹ 35.52₹ 29.45₹ 22.95₹ 16.72₹ 22.45
Diluted EPS
₹ 35.52₹ 29.45₹ 22.95₹ 16.72₹ 22.45
Weighted Average Shares Outstanding
0.00 104.62M 104.62M 104.62M 104.62M
Weighted Average Shares Outstanding (Diluted)
0.00 104.62M 104.62M 104.62M 104.62M
Currency in INR

Concord Biotech Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis